Literature DB >> 26492353

Correction: Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Fariba Ahmadizar, N Charlotte Onland-Moret, Anthonius de Boer, Geoffrey Liu, Anke H Maitland-van der Zee.   

Abstract

Entities:  

Year:  2015        PMID： 26492353      PMCID： PMC4619590          DOI： 10.1371/journal.pone.0141704

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


× No keyword cloud information.
The phrases “log hazard ratio” and “log HR” appear incorrectly throughout the article and Supporting Information files, with the exception of the “Data analysis” subsection, Fig 5, and Fig 6. The correct terminology in all other cases should be “hazard ratio” and “HR.”
  1 in total

Review 1.  Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Fariba Ahmadizar; N Charlotte Onland-Moret; Anthonius de Boer; Geoffrey Liu; Anke H Maitland-van der Zee
Journal:  PLoS One       Date:  2015-09-02       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.